Spencer Health Solutions – a health technology provider focused on improving patient engagement and medication adherence for clinical trials and commercial pharmaceutical programs while also easing the burden of medication management for patients and caregivers – recently announced the successful close of its Series D funding round, having raised an initial $43 million with additional funding expected before the end of the year. This funding round reflected the progress made at Spencer Health Solutions and the significant market response to its platform.
Spencer Health Solutions’ spencer medication dispensing technology has served over 5,800 patients in the US, Canada, and Europe. This latest round of capital will support continued growth in those markets, including capital for devices, new operational team members, and sales and marketing resources. The company aims to continue helping pharmaceutical companies and providers better serve patients from their homes.
KEY QUOTES:
“Our Series D will convert our debt to equity and bring in new capital to help us scale pharmaceutical company growth in clinical trials and patient support services from the home. This round of funding reflects our progress in building partnerships with several major pharmaceutical companies, global clinical packagers, and regional and national specialty pharmacies. It will also help support and scale several major chronic care provider contracts recently awarded in the US, Canada, and Europe. It is an exciting time at Spencer Health Solutions.”
— Tom Rhoads, CEO of Spencer Health Solutions
